192 Development of the proteogenomic antibody repertoire assay for anti-tumor antibody discovery
Yoshinobu Koguchi(Providence Portland Medical Center), William L. Redmond(Providence St. Vincent Medical Center), Noriko Iwamoto(Shimadzu (Japan)), Jordan E. Krull(The Ohio State University), Qin Ma(The Ohio State University), Lauren E Hamilton(Providence Portland Medical Center), Mark P. Rubinstein(The Ohio State University), Tanisha Christie(Providence Portland Medical Center), Paul W. Sanders(Deakin University), Mitch A. Phelps(The Ohio State University), Bernard A. Fox(Oregon Health & Science University), Brian Piening(Providence College), Zhiwei Hu(The Ohio State University Wexner Medical Center), Zihai Li(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Takashi Shimada(Keio University)
Cited by 0
Related Papers
Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism
|Journal of Clinical Investigation|2004|1.4k
The NASA Twins Study: A multidimensional analysis of a year-long human spaceflight
|Science|2019|1.1k
Longitudinal multi-omics of host–microbe dynamics in prediabetes
|Nature|2019|620
Cancer immunotherapy: Opportunities and challenges in the rapidly evolving clinical landscape
|European Journal of Cancer|2017|565